List view / Grid view



Rethinking Collaboration in Biologics Discovery

4 April 2017 | By

In this webinar, Anne Goupil-Lamy, Ph.D. from BIOVIA demonstrated, using a case study, the value of bringing real time data together during the project: genomics data, predictive models, and experimental assay data...

Tecan simplifies large molecule bioanalysis

2 February 2016 | By

Tecan has launched a fully automated affinity purification solution for the extraction of large biomolecules, such as proteins, antibodies and antibody-drug conjugates. This set-up takes advantage of the new Thermo Scientific™ MSIA™ Streptavidin EVO microcolumns, which have been specifically designed for use on Tecan’s proven Freedom EVO® platform. In combination…

UCB secures multi-million pound funding boost from UK Government

30 March 2015 | By

UCB has announced that its joint bid with five other UK-based organisations has been selected as a recipient of the Government’s 2014 Advanced Manufacturing Supply Chain Initiative (AMSCI), which will result in a £6.2 million grant to support the development of novel biologic treatments.

TandAbs: potent and well-manufacturable bi-specific antibodies for immunooncology

10 March 2015 | By

The bi-specific antibody format is becoming the preferred antibody modality for current development projects in the pharmaceutical industry. This is due to an unsurpassed increase in functional activity relative to traditional mono-specific monoclonal antibodies, and a breakthrough in manufacturability enabled by novel designs. One such bi-specific format, the TandAb, produces…

Send this to a friend